PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • Labeling Updates

    • K e y
    • BlackBox_opt Boxed Warning
    • Triangle_opt Other Warnings*
      *Warnings and Precautions; Adverse Reactions; Drug Interactions; and Contraindications
    • Circle_opt Updates to Indications/Dosage
    • Diamond_opt Other Updates
      Other labeling changes; added to PDR database
    Diamond_opt
    Berinert (C1 esterase inhibitor (human))
    Triangle_opt
    Depakote ER (divalproex sodium)
    Triangle_opt
    Humira (adalimumab)
    Triangle_opt
    Jakafi (ruxolitinib)
    Triangle_opt
    Circle_opt
    Diamond_opt
    Kaletra (lopinavir/ritonavir)
    Triangle_opt
    Mavyret (glecaprevir/pibrentasvir)
    Triangle_opt
    Diamond_opt
    Moderiba (ribavirin)
    Triangle_opt
    Niaspan (niacin)
    Diamond_opt
    Nimbex (cisatracurium besylate)
    Triangle_opt
    Circle_opt
    Circle_opt
    Diamond_opt
    Sprix (ketorolac tromethamine)
    Triangle_opt
    Technivie (ombitasvir/paritaprevir/ritonavir)
    Diamond_opt
    Trilipix (fenofibric acid)
    Triangle_opt
    Circle_opt
    Diamond_opt
    Trokendi XR (topiramate)
    Triangle_opt
    Diamond_opt
    Venclexta (venetoclax)
    Triangle_opt
    Diamond_opt
    Viekira Pak (dasabuvir, ombitasvir/paritaprevir/ritonavir)
    Triangle_opt
    Viekira XR (dasabuvir/ombitasvir/paritaprevir/ritonavir)
  •  

    To have full prescribing information faxed or mailed to you, call 1-800-261-2313.

    The FDA encourages healthcare professionals to recognize and report misleading prescription drug advertising. To report: call 855-RX-BADAD (855-792-2323) or email BadAd@fda.gov. For more information, visit www.fda.gov.
    Report adverse events to MedWatch.